Temple Health Chest Initiative (THCI 2.0)
Recruiting · NCT06933758 · Observational (researchers observe without assigning treatment) · Lead sponsor: Temple University
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
Chronic obstructive pulmonary disease is highly prevalent globally, with considerable morbidity and mortality associated. In the US, it is the 4th leading cause of death, as well as contributing to significant costs on healthcare utilization including hospitalization. Population-based screening for COPD has not been recommended by the US Preventative Services Task Force (USPSTF). However, LDCT screening for lung cancer in patients aged 50- 80 with ≥ 20 pack year smoking has been shown to improve survival. COPD is highly prevalent within LCS programs, with estimated rates of obstructive lung function of up to 59% and evidence of emphysema on CT scan in around 70%.
Who can take part
Inclusion criteria
- 50 to 80 years old
- Screened for early lung cancer using low dose CT imaging
Exclusion criteria
- Under 50; over 80 years old
- No lung cancer screening
Where it is running
1 location listed across 1 US state.
- Temple University Of the Commonwealth System of Higher Education - Philadelphia, Pennsylvania, United States